(Q45966946)

English

Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

0 references

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

Charles Lavigne

3

object named as

Charles Lavigne

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

author name string

Ying Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Simon Chewchuk

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Sophie Brûlé

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Genevieve Pilon

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Vanessa Houde

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Aimin Xu

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Andre Marette

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

Gary Sweeney

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

publication date

16 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

297

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

E657-64

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

The cardiovascular safety of rosiglitazone

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Effects of rosiglitazone and oleic acid on UCP-3 expression in L6 myotubes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin actions in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

An intracellular role for the C1q-globular domain.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

The expression of TNF alpha by human muscle. Relationship to insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin independently predicts metabolic syndrome in overweight Latino youth.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Post-translational modifications of adiponectin: mechanisms and functional implications.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Insulin resistance and impaired functional vasodilation in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Adiponectin Ameliorates Dyslipidemia Induced by the Human Immunodeficiency Virus Protease Inhibitor Ritonavir in Mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00186.2009

21 January 2018

Identifiers

10.1152/AJPENDO.00186.2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19531641

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45966946&oldid=1512248504"